创伤性脑损伤评估和管理设备市场－全球产业规模、份额、趋势、机会及预测（按设备、技术、最终用途、地区和竞争格局划分，2021-2031年）

全球创伤性脑损伤评估和管理设备市场预计将从 2025 年的 37.8 亿美元增长到 2031 年的 57.6 亿美元，复合年增长率为 7.27%。

此市场领域涵盖用于评估和管理由外部衝击引起的颅内创伤的诊断设备和治疗系统，其主要产品线包括颅内压监测器、先进的神经影像设备和标靶温度管理解决方案。推动这一增长的关键因素包括全球道路交通事故频繁、人口老化导致跌倒相关损伤增加，以及运动相关脑震盪通讯协定的加强，这些因素都促使人们对精准的现场评估设备的需求日益增长。

然而，由于轻度脑损伤普遍未被诊断，市场面临许多障碍，常常导致医疗干预延误，并限制了设备的普及。这种认知不足严重阻碍了诊断技术在重症监护环境之外的应用。根据美国脑损伤协会的数据，到2025年，81%的美国成年人将无法辨识脑震盪属于创伤性脑损伤。这种巨大的认知差距阻碍了早期检测工作，并对评估解决方案的更广泛应用和推广构成了重大障碍。

市场驱动因素

军事和国防领域对神经创伤解决方案的日益重视，源于作战和训练场景中对快速、即用型评估能力的迫切需求，这成为市场成长的强劲驱动力。国防机构优先采购坚固耐用的携带式设备和血清生物标记检测方法，以有效管理爆炸引起的神经创伤，并减轻人员的长期神经损伤，从而催生了对能够在标准临床设施之外可靠运行的技术的需求。根据美国军事卫生系统于2025年8月发布的《2024年国防部全球创伤性脑损伤统计》报告，2024年现役军人中新增创伤性脑损伤（TBI）病例18,376例，这进一步证实了国防部门作为早期检测和管理设备主要采购方的关键地位。

同时，政府支持计画和宣传宣传活动正在改变市场格局，促进对轻度创伤性脑损伤的识别，而这些损伤往往被忽视。这些教育措施鼓励人们识别症状并寻求医疗救助，从而扩大了符合评估和治疗条件的患者群体。根据美国脑损伤协会于2025年3月发布的《2025年脑损伤公众意识报告》，约40%的美国成年人承认经历过脑损伤症状，这表明如果将这些潜在病例纳入临床实践，将具有巨大的市场潜力。这种积极主动的管理趋势也反映在职业运动领域。 2025年2月，美国国家美式足球联盟（NFL）报告称，加强的安全措施使得2024赛季的脑震盪发生率降至历史新低，仅182例，证明严格的评估通讯协定能够有效降低受伤风险。

市场挑战

全球创伤性脑损伤评估和管理设备市场成长的主要障碍之一是轻度脑损伤的普遍漏诊。这个问题导致颅内创伤的实际发生率与接受临床治疗的患者人数之间存在显着差异。当症状被忽视或未能立即与神经损伤联繫起来时，患者实际上无法获得诊断工具和治疗系统。因此，评估技术的应用仍主要集中在重症创伤中心，阻碍了市场向基层医疗机构、运动医学诊所和门诊復健中心等更易普及的场所扩展。

无法准确识别患者直接抑制了对诊断技术的需求。根据美国脑损伤协会 (BIAA) 2025 年的数据，不到四分之一的美国成年人曾被医疗专业人员询问过脑损伤史。这种低频率的临床访谈表明，许多潜在病例仍未被调查。因此，除非常规筛检成为常态，否则神经影像和监测设备的下游应用将无法满足实际的医疗需求，这将直接阻碍该行业製造商的产生收入。

市场趋势

人工智慧 (AI) 和机器学习在预测分析领域的融合，透过自动识别严重的颅内异常，正在变革神经创伤护理。先进的演算法正被整合到诊断流程中，能够基于影像数据快速检测和量化脑损伤，从而显着缩短紧急情况下的治疗时间。这项技术进步有助于同时分析各种生物标记和显像模式，为临床医生提供即时、数据驱动的决策支援。例如，2025 年 10 月，Qure.ai 在一份关于其「第 19 项 FDA核准」的新闻稿中宣布，其 qER-CTA 演算法已获得核准。该演算法是一款 AI 工具，可支援神经重症监护病例的快速分流。这项批准进一步扩展了该公司用于自动检测颅内出血和急性脑部急症的解决方案套件。

随着人工智慧技术的进步，携带式照护现场诊断设备的广泛应用，使得创伤性脑损伤（TBI）的评估范围扩展到了院外环境。这些携带式设备能够对颅内出血进行即时评估，即使在资源匮乏、传统CT扫描难以进行的环境中，例如偏远地区或救护车上。透过利用近红外线光谱等技术，这些设备能够进行可靠的现场筛检，并支援快速的患者分诊。剑桥大学于2025年7月发表的一篇题为《InfraScanner的性能》的研究论文指出，携带式InfraScanner 2000在检测创伤患者的颅内出血方面，阴性预测值高达94.2%，凸显了其在无法进行全面神经影像诊断的环境中作为一线分诊设备的价值。

目录

第一章概述

第二章调查方法

第三章执行摘要

第四章：客户评价

第五章 全球创伤性脑损伤评估与管理设备市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 依设备分类（影像诊断设备（核磁共振造影系统、 X光设备、CT设备等）、监测设备）
  • 透过技术手段（颅内压监测、脑组织氧分压（pBrO2））
  • 透过申请（医院、诊断中心等）
  • 按地区
  • 按公司（2025 年）
• 市场地图

6. 北美创伤性脑损伤评估与管理设备市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 我们
  • 加拿大
  • 墨西哥

7. 欧洲创伤性脑损伤评估与管理设备市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

8. 亚太地区创伤性脑损伤评估与管理设备市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

9. 中东和非洲创伤性脑损伤评估和管理设备市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

10. 南美洲创伤性脑损伤评估与管理设备市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 司机
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 最新进展

第十三章 全球创伤性脑损伤评估与管理设备市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的可能性
• 供应商电力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• Integra LifeSciences Corp
• BioDirection Inc
• Nihon Kohden Tokyo Corp
• Compumedics Ltd
• InfraScan Inc
• Oculogica Inc
• RAUMEDIC AG

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Traumatic Brain Injuries Assessment And Management Devices Market is projected to expand from a valuation of USD 3.78 billion in 2025 to USD 5.76 billion by 2031, reflecting a compound annual growth rate of 7.27%. This market sector comprises diagnostic apparatus and therapeutic systems intended to assess and manage intracranial trauma caused by external impact, with key product offerings ranging from intracranial pressure monitors to advanced neuroimaging equipment and targeted temperature management solutions. The primary factors fueling this growth include the escalating global frequency of road traffic accidents and the rising number of fall-related injuries within the aging population, alongside intensified protocols for sports-related concussions that drive the need for accurate on-field assessment instruments.

However, the market faces a substantial hurdle due to the prevalent underdiagnosis of mild brain injuries, a factor that frequently delays medical intervention and restricts device usage. This lack of recognition severely curtails the implementation of diagnostic technologies outside of critical care environments. Data from the Brain Injury Association of America indicates that in 2025, 81% of adults in the United States failed to identify concussions as traumatic brain injuries. This profound gap in awareness obstructs early detection efforts and stands as a significant impediment to the wider adoption and expansion of assessment solutions.

Market Driver

The growing integration of neuro-trauma solutions within military and defense sectors serves as a robust engine for market growth, propelled by the urgent necessity for rapid, field-ready assessment capabilities in combat and training scenarios. Defense entities are emphasizing the procurement of ruggedized handheld units and serum biomarker assays to effectively manage blast-induced neurotrauma and mitigate long-term neurological damage among personnel, creating a demand for technologies that function reliably outside standard clinical facilities. As highlighted by the Military Health System in August 2025, the '2024 DOD Worldwide Numbers for TBI' report documented 18,376 new traumatic brain injury diagnoses among active-duty service members in 2024, confirming the defense sector's pivotal role as a major purchaser of early-detection and management devices.

Concurrently, supportive government programs and public awareness campaigns are transforming the market by enhancing the identification of mild traumatic brain injuries that were previously overlooked. These educational initiatives empower individuals to recognize symptoms and pursue medical care, thereby expanding the patient population eligible for assessment and therapy. According to the Brain Injury Association of America's '2025 Public Perceptions of Brain Injury Report' released in March 2025, nearly four out of ten U.S. adults acknowledged experiencing brain injury symptoms, signaling significant market potential if these latent cases are brought into the clinical fold. This trend toward proactive management is also reflected in professional sports; the NFL reported in February 2025 that stricter safety mandates resulted in a record low of 182 concussions during the 2024 season, proving that rigorous assessment protocols are successfully reducing injury risks.

Market Challenge

A major obstacle obstructing the growth of the Global Traumatic Brain Injuries Assessment and Management Devices Market is the pervasive underdiagnosis of mild brain injuries. This issue establishes a considerable disparity between the actual occurrence of intracranial trauma and the number of patients who receive clinical care; when symptoms are ignored or not immediately linked to neurological trauma, the avenue for employing diagnostic tools and therapeutic systems is effectively closed. As a result, the utilization of assessment technologies remains disproportionately focused in high-acuity trauma centers, preventing the market from extending into primary care facilities, sports medicine clinics, and outpatient rehabilitation centers where broader adoption is possible.

This inability to accurately identify patients directly curbs the demand for diagnostic technologies. Data from the Brain Injury Association of America in 2025 reveals that fewer than one in four adults in the United States reported being questioned by a healthcare provider regarding a history of brain injury. Such a low frequency of clinical inquiry implies that a multitude of potential cases go uninvestigated. Consequently, as long as routine screening remains uncommon, the downstream application of neuroimaging modalities and monitoring devices will fail to match the actual medical necessity, thereby directly impeding revenue generation for manufacturers within this industry.

Market Trends

The incorporation of Artificial Intelligence and Machine Learning for Predictive Analytics is transforming neurotrauma care by automating the recognition of severe intracranial anomalies. Sophisticated algorithms are increasingly being integrated into diagnostic workflows to swiftly detect and quantify brain injuries based on imaging data, substantially shortening the time to treatment for urgent conditions. This technological advancement facilitates the concurrent analysis of various biomarkers and imaging modalities, offering clinicians instant, data-backed decision support. For instance, in October 2025, Qure.ai announced in a press release regarding its '19th FDA Clearance' that it received approval for the qER-CTA algorithm, an AI tool engineered to aid in the rapid triage of neurocritical cases, thereby broadening its suite of solutions for automatically detecting intracranial hemorrhages and acute brain emergencies.

Parallel to these AI developments, the proliferation of Handheld and Point-of-Care Diagnostic Devices is extending the scope of TBI assessment into non-hospital settings. These portable units permit the immediate assessment of intracranial bleeding in resource-constrained environments, such as remote locations or ambulances, where access to conventional computed tomography is limited. By leveraging technologies such as near-infrared spectroscopy, these devices facilitate dependable on-site screening that supports rapid patient triage. As reported by the University of Cambridge in a July 2025 research publication titled 'Performance of the InfraScanner', the handheld InfraScanner 2000 exhibited a negative predictive value of 94.2% for detecting intracranial bleeding in trauma patients, highlighting its value as a frontline triage instrument when comprehensive neuroimaging is inaccessible.

Key Market Players

• Integra LifeSciences Corp
• BioDirection Inc
• Nihon Kohden Tokyo Corp
• Compumedics Ltd
• InfraScan Inc
• Oculogica Inc
• RAUMEDIC AG

Report Scope

In this report, the Global Traumatic Brain Injuries Assessment And Management Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Traumatic Brain Injuries Assessment And Management Devices Market, By Devices

• Imaging Devices (Magnetic Resonance Imaging (MRI) Devices, X-Ray, Computed Tomography, Others)
• Monitoring Devices

Traumatic Brain Injuries Assessment And Management Devices Market, By Technique

• Intracranial pressure monitoring
• Partial pressure of oxygen in brain tissue (pBrO2)

Traumatic Brain Injuries Assessment And Management Devices Market, By End-Use

• Hospitals
• Diagnostic centers
• Others

Traumatic Brain Injuries Assessment And Management Devices Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Traumatic Brain Injuries Assessment And Management Devices Market.

Available Customizations:

Global Traumatic Brain Injuries Assessment And Management Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Traumatic Brain Injuries Assessment And Management Devices Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Devices (Imaging Devices (Magnetic Resonance Imaging (MRI) Devices, X-Ray, Computed Tomography, Others), Monitoring Devices)
  • 5.2.2. By Technique (Intracranial pressure monitoring, Partial pressure of oxygen in brain tissue (pBrO2))
  • 5.2.3. By End-Use (Hospitals, Diagnostic centers, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Traumatic Brain Injuries Assessment And Management Devices Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Devices
  • 6.2.2. By Technique
  • 6.2.3. By End-Use
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Traumatic Brain Injuries Assessment And Management Devices Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Devices
      • 6.3.1.2.2. By Technique
      • 6.3.1.2.3. By End-Use
  • 6.3.2. Canada Traumatic Brain Injuries Assessment And Management Devices Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Devices
      • 6.3.2.2.2. By Technique
      • 6.3.2.2.3. By End-Use
  • 6.3.3. Mexico Traumatic Brain Injuries Assessment And Management Devices Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Devices
      • 6.3.3.2.2. By Technique
      • 6.3.3.2.3. By End-Use

7. Europe Traumatic Brain Injuries Assessment And Management Devices Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Devices
  • 7.2.2. By Technique
  • 7.2.3. By End-Use
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Traumatic Brain Injuries Assessment And Management Devices Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Devices
      • 7.3.1.2.2. By Technique
      • 7.3.1.2.3. By End-Use
  • 7.3.2. France Traumatic Brain Injuries Assessment And Management Devices Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Devices
      • 7.3.2.2.2. By Technique
      • 7.3.2.2.3. By End-Use
  • 7.3.3. United Kingdom Traumatic Brain Injuries Assessment And Management Devices Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Devices
      • 7.3.3.2.2. By Technique
      • 7.3.3.2.3. By End-Use
  • 7.3.4. Italy Traumatic Brain Injuries Assessment And Management Devices Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Devices
      • 7.3.4.2.2. By Technique
      • 7.3.4.2.3. By End-Use
  • 7.3.5. Spain Traumatic Brain Injuries Assessment And Management Devices Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Devices
      • 7.3.5.2.2. By Technique
      • 7.3.5.2.3. By End-Use

8. Asia Pacific Traumatic Brain Injuries Assessment And Management Devices Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Devices
  • 8.2.2. By Technique
  • 8.2.3. By End-Use
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Traumatic Brain Injuries Assessment And Management Devices Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Devices
      • 8.3.1.2.2. By Technique
      • 8.3.1.2.3. By End-Use
  • 8.3.2. India Traumatic Brain Injuries Assessment And Management Devices Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Devices
      • 8.3.2.2.2. By Technique
      • 8.3.2.2.3. By End-Use
  • 8.3.3. Japan Traumatic Brain Injuries Assessment And Management Devices Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Devices
      • 8.3.3.2.2. By Technique
      • 8.3.3.2.3. By End-Use
  • 8.3.4. South Korea Traumatic Brain Injuries Assessment And Management Devices Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Devices
      • 8.3.4.2.2. By Technique
      • 8.3.4.2.3. By End-Use
  • 8.3.5. Australia Traumatic Brain Injuries Assessment And Management Devices Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Devices
      • 8.3.5.2.2. By Technique
      • 8.3.5.2.3. By End-Use

9. Middle East & Africa Traumatic Brain Injuries Assessment And Management Devices Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Devices
  • 9.2.2. By Technique
  • 9.2.3. By End-Use
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Traumatic Brain Injuries Assessment And Management Devices Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Devices
      • 9.3.1.2.2. By Technique
      • 9.3.1.2.3. By End-Use
  • 9.3.2. UAE Traumatic Brain Injuries Assessment And Management Devices Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Devices
      • 9.3.2.2.2. By Technique
      • 9.3.2.2.3. By End-Use
  • 9.3.3. South Africa Traumatic Brain Injuries Assessment And Management Devices Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Devices
      • 9.3.3.2.2. By Technique
      • 9.3.3.2.3. By End-Use

10. South America Traumatic Brain Injuries Assessment And Management Devices Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Devices
  • 10.2.2. By Technique
  • 10.2.3. By End-Use
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Traumatic Brain Injuries Assessment And Management Devices Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Devices
      • 10.3.1.2.2. By Technique
      • 10.3.1.2.3. By End-Use
  • 10.3.2. Colombia Traumatic Brain Injuries Assessment And Management Devices Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Devices
      • 10.3.2.2.2. By Technique
      • 10.3.2.2.3. By End-Use
  • 10.3.3. Argentina Traumatic Brain Injuries Assessment And Management Devices Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Devices
      • 10.3.3.2.2. By Technique
      • 10.3.3.2.3. By End-Use

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Traumatic Brain Injuries Assessment And Management Devices Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Integra LifeSciences Corp
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. BioDirection Inc
• 15.3. Nihon Kohden Tokyo Corp
• 15.4. Compumedics Ltd
• 15.5. InfraScan Inc
• 15.6. Oculogica Inc
• 15.7. RAUMEDIC AG

16. Strategic Recommendations

17. About Us & Disclaimer